NDC 0002-4454-01 - Zyprexa
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0002-4454
- Requested NDC
- 0002-4454-01
- Package NDCs from labels
- 0002-4454-01, 0002-4454-85
- Manufacturer
- Eli Lilly and Company
- Effective date
- 2025-11-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Zyprexa - Eli Lilly and Company | Eli Lilly and Company | 2025-11-18 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0002-4454-01 | ZYPREXA Zydis | 1 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 1 | 67 | |
| 0002-4454-01 | ZYPREXA Zydis | 1 in 1 DOSE PACK | TABLET, ORALLY DISINTEGRATING | 1 | 67 | |
| 0002-4454-85 | ZYPREXA Zydis | 30 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 30 | 67 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0002-4454 | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ] | 66 | Legacy NDC, 3 package rows | 20250110_d5051fbc-846b-4946-82df-341fb1216341.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0002-4454-01 | EA - Each | 0002-4454 | 7e221558-7584-4b8b-b359-bbce11fe7e20 | 1 | 2012-07-24 |
| 0002-4454-85 | EA - Each | 0002-4454 | 9879037d-1deb-4639-8596-ead22339987d | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 4d39ed7a-ca80-893c-e063-6294a90a03e7 | 2026-03-17 | Warnings | 15FIX9V2JP |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 4d3a0a92-b0de-a1ea-e063-6294a90a8508 | 2026-03-17 | Warnings | 15FIX9V2JP 1K09F3G675 |
| Coral Isle SPF 50 Mineral Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | Derma Care Research Labs, LLC | 0aafab44-0481-2a22-e063-6294a90abef2 | 2026-03-17 | Warnings | 15FIX9V2JP |
| SUMMER FRIDAYS SHADEDROPS BROAD SPECTRUM MINERAL MILK SUNSCREEN SPF 50 | TITANIUM DIOXIDE, ZINC OXIDE | Summer Friday's LLC | 4d3e982f-3489-dce2-e063-6294a90a1b9d | 2026-03-17 | Warnings | 15FIX9V2JP |
| Sei Bella Tinted BB Moisturizing Cream | 410 N | Melaleuca Inc. | 2f380433-3369-9d05-e063-6394a90a6479 | 2026-03-17 | Warnings | 15FIX9V2JP |
| Sei Bella Tinted BB Moisturizing Cream | 115 N | Melaleuca Inc. | 2f132cc0-e8e3-35e3-e063-6394a90a4f3d | 2026-03-17 | Warnings | 15FIX9V2JP |
| Tinted Sunscreen Broad SPF30 | TINTED SUNSCREEN BROAD SPF30 | DOSCHER FAMILY HEALTH NP P.C. | 4d4021ba-4b29-6b81-e063-6294a90a5ea7 | 2026-03-17 | Warnings | 15FIX9V2JP |
| Olanzapine | OLANZAPINE | HEC Pharm USA Inc. | 4d1b83db-54db-d51f-e063-6394a90a4a69 | 2026-03-16 | Boxed warning, Warnings, Adverse reactions | 312076 351108 351107 314155 N7U69T4SZR |
| OLANZAPINE | OLANZAPINE | HEC Pharm USA Inc. | 4d34f8f3-edc8-0a68-e063-6394a90a9c1f | 2026-03-16 | Boxed warning, Warnings, Adverse reactions | 200034 283639 312079 312077 314154 312078 N7U69T4SZR |
| HYDRATING TINTED MOISTURIZER SPF50 | HYDRATING TINTED MOISTURIZER SPF50 | NING PTE. LTD. | 4cf8d3d3-eebf-2da0-e063-6294a90a7065 | 2026-03-14 | Warnings | 15FIX9V2JP |
| TINTED WATERY SUNSCREEN | TITANIUM DIOXIDE, ZINC OXIDE | KSISTERS PTE. LTD. | 4ced53d0-8bfc-ff8e-e063-6294a90a9dbd | 2026-03-13 | Warnings | 15FIX9V2JP |
| Daily Moisturizing Mineral Sunscreen | BROAD SPECTRUM SPF30 | EDINA PLASTIC SURGERY,LTD. | 4d056e2b-5813-da42-e063-6294a90ac519 | 2026-03-13 | Warnings | 15FIX9V2JP |
| Neutrogena Healthy Skin Liquid Makeup Broad Spectrum SPF 20 - Cool Bronze 440C | TITANIUM DIOXIDE | Kenvue Brands LLC | 4c335d9c-40ca-c0ce-e063-6394a90ac20a | 2026-03-11 | Warnings | 15FIX9V2JP |
| Skin Irritations and Itch Relief | AGARICUS MUSCARIUS, ALUMINA, ANAGALLIS ARVENSIS, ANTIMONIUM TARTARICUM, APIS MELLIFICA, ARSENICUM ALBUM, ARSENICUM IODATUM, BOVISTA, CAUSTICUM, DOLICHOS PRURIENS, FAGOPYRUM ESCULENTUM, GRAPHITES, KALI MURIATICUM, MURIATICUM ACIDUM, OLEANDER, PETROLEUM, PIX LIQUIDA, RADIUM BROMATUM (12X, 30X, 1LM), RHUS TOX, SELENIUM METALLICUM, SULPHUR AND URTICA URENS. | King Bio Inc. | d139d2f1-0369-4963-9f3d-c4cc0f1ea2dd | 2026-03-10 | Warnings | QTT17582CB |
| Olanzapine | OLANZAPINE | Dr.Reddy's Laboratories Limited | aff02cff-d079-bc82-6182-a24c4c6e09a6 | 2026-03-09 | Boxed warning, Warnings, Adverse reactions | 312076 351108 351107 314155 N7U69T4SZR |
| Olanzapine | OLANZAPINE | Dr. Reddy's Laboratories Inc. | d474d5a9-d338-511d-5823-567c0a1bbf4d | 2026-03-09 | Boxed warning, Warnings, Adverse reactions | 312079 314154 312078 N7U69T4SZR |
| OLANZAPINE | OLANZAPINE | Anthea Pharma Private Limited | e6ffcc56-63f9-4b12-a07a-c6177ffef5e8 | 2026-03-06 | Boxed warning, Warnings, Adverse reactions | 485968 N7U69T4SZR |
| Artificial Tears | GLYCERIN | Preferred Pharmaceuticals Inc. | dd646c72-8f47-43c6-a734-db0dcc8cd4d1 | 2026-03-06 | Warnings | 3NXW29V3WO |
| Olanzapine | OLANZAPINE | Macleods Pharmaceuticals Limited | 8e095987-bdea-42f2-9550-c7155cf07d30 | 2026-03-05 | Boxed warning, Warnings, Adverse reactions | 200034 283639 312079 312077 314154 312078 N7U69T4SZR |
| cle de peau BEAUTE RADIANT FLUID FOUNDATION NATURAL B50 | OCTINOXATE AND TITANIUM DIOXIDE | SHISEIDO AMERICAS CORPORATION | 4490f968-46b6-44d2-af2d-5130b52c8861 | 2026-03-05 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.